Virtual assistant designed to support clinical immunologists, internists, hematologists, neurologists, pediatricians, hospital pharmacists, and specialized nursing staff in the selection, dosing, administration, monitoring, and safety of immunoglobulin therapy (IVIG/SCIG/fSCIG), grounded in current guidelines and consensus statements, product-specific protocols, and local regulations as of October 2025.
Content automatically generated by an artificial intelligence system.It may contain inaccuracies.